According to our (Global Info Research) latest study, the global Bempedoic Acid API market size was valued at US$ 125 million in 2025 and is forecast to a readjusted size of US$ 294 million by 2032 with a CAGR of 13.2% during review period.
Bempedoic acid is an adenosine triphosphate-citrate lyase (ACL) inhibitor that reduces low-density lipoprotein cholesterol (LDL-C) by inhibiting the synthesis of cholesterol in the liver, an enzyme involved in the synthesis of fatty acids and cholesterol. Bempedoic acid is used to treat dyslipidaemia and other cardiometabolic risk factors by reducing LDL-C.
Against the backdrop of the growing global burden of cardiovascular disease and the increasing prevalence of statin tolerance, bempedoic acid, a next-generation ATP citrate lyase (ACL) inhibitor, is gaining both clinical and market recognition. Its oral, non-statin, and ezetimibe-compatible properties offer a new long-term lipid-lowering strategy for patients with high cholesterol, creating a well-structured and promising market for APIs.
Currently, the bempedoic acid API market is still in its early commercialization phase, dominated by patents and gradually expanding with formulations. The originator, Esperion Therapeutics, possesses core technological advantages and is driving sales expansion through licensing agreements and a global presence. On the API manufacturing side, companies such as Metrochem API in India, Lee Pharma, and Sun Pharmaceutical, and Conscientia Industrial in China, are actively developing large-scale production and global registration capabilities, forming a global supply chain centered on "origin research-led, India-China manufacturing support."
It is expected that with the further promotion of the formulation in the European, American, and Asia-Pacific markets, and the gradual approach of the generic drug window, the bempedoic acid API market will enter a period of stable growth in the next 3-5 years, becoming a potential sub-category in the cardiovascular metabolic field with a clear structure, orderly competition, and significant room for value enhancement.
This report is a detailed and comprehensive analysis for global Bempedoic Acid API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bempedoic Acid API market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2021-2032
Global Bempedoic Acid API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2021-2032
Global Bempedoic Acid API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2021-2032
Global Bempedoic Acid API market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bempedoic Acid API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bempedoic Acid API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Esperion, Metrochem API Pvt Ltd, Lee Pharma, Conscientia Industrial Co., Ltd, Sun Pharmaceutical, China Fortune Way Company, Shanghai Yingrui Biopharma Co., Ltd., Viruj Pharma, Henan Dongyao Medical Technology Co., Ltd., Speranza Chemical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bempedoic Acid API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.98
0.99
Others
Market segment by Application
Pharmaceutical Manufacturing
Scientific Research
Major players covered
Esperion
Metrochem API Pvt Ltd
Lee Pharma
Conscientia Industrial Co., Ltd
Sun Pharmaceutical
China Fortune Way Company
Shanghai Yingrui Biopharma Co., Ltd.
Viruj Pharma
Henan Dongyao Medical Technology Co., Ltd.
Speranza Chemical Co., Ltd.
Rui Laboratories
Optimus Drugs Pvt LTD
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bempedoic Acid API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bempedoic Acid API, with price, sales quantity, revenue, and global market share of Bempedoic Acid API from 2021 to 2026.
Chapter 3, the Bempedoic Acid API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bempedoic Acid API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Bempedoic Acid API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bempedoic Acid API.
Chapter 14 and 15, to describe Bempedoic Acid API sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Bempedoic Acid API. Industry analysis & Market Report on Bempedoic Acid API is a syndicated market report, published as Global Bempedoic Acid API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Bempedoic Acid API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.